J. Riveline

发表

Real-time continuous glucose monitoring (CGM) integrated into the treatment of type 1 diabetes: consensus of experts from SFD, EVADIAC and SFE.

E. Renard, A. Penfornis, P. Benhamou, 2012, Diabetes & metabolism.

Practical implementation of automated closed-loop insulin delivery: a French position statement.

G. Charpentier, E. Renard, A. Farret, 2020, Diabetes & metabolism.

One‐year metreleptin improves insulin secretion in patients with diabetes linked to genetic lipodystrophic syndromes

F. Travert, C. Vigouroux, F. Andreelli, 2016, Diabetes, obesity & metabolism.

Incretin-based therapy and pancreatic beta cells.

S. Chon, J. Gautier, J. Riveline, 2014, Diabetes & metabolism.

The clinical variability of maternally inherited diabetes and deafness is associated with the degree of heteroplasmy in blood leukocytes.

H. Gin, G. Charpentier, P. Massin, 2009, The Journal of clinical endocrinology and metabolism.

Oxidative and energetic stresses mediate beta-cell dysfunction induced by PGC-1α.

F. Foufelle, J. Gautier, J. Riveline, 2017, Diabetes & metabolism.

INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetes

E. Bonifacio, M. Knip, D. Dunger, 2022, Trials.

Glucagon-secretion inhibition using somatostatin: An old hormone for the treatment of diabetes-associated pancreatectomy.

J. Gautier, J. Riveline, P. Boudou, 2017, Diabetes & metabolism.

Early macrophage response to obesity encompasses Interferon Regulatory Factor 5 regulated mitochondrial architecture remodelling

J. Rieusset, C. Blugeon, S. Lameiras, 2022, Nature Communications.

Metabolic roles of PGC-1α and its implications for type 2 diabetes.

J. Gautier, J. Riveline, B. Blondeau, 2015, Diabetes & metabolism.

Exposure to glucocorticoids in the first part of fetal life is associated with insulin secretory defect in adult humans

E. Vicaut, J. Gautier, J. Riveline, 2020 .

Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: the SFDT1 study.

E. Vicaut, A. Bonnefond, R. Roussel, 2021, Diabetes & metabolism.

Practical implementation, education and interpretation guidelines for continuous glucose monitoring: A French position statement.

G. Charpentier, E. Renard, A. Farret, 2017, Diabetes & Metabolism.

Indication, organization, practical implementation and interpretation guidelines for retrospective CGM recording: A French position statement.

G Charpentier, S Franc, B Catargi, 2015, Diabetes & metabolism.

Can the ESC/EAS LDL-cholesterol target in patients with diabetes and high cardiovascular risk be achieved in clinical practice? Results from an ambulatory multidisciplinary diabetes center cohort.

J. Dillinger, J. Gautier, J. Riveline, 2018, Diabetes & metabolism.

Continuous intraperitoneal insulin infusion does not increase the risk of organ-specific autoimmune disease in type 1 diabetic patients: results of a multicentric, comparative study.

N. Jeandidier, B. Catargi, V. Melki, 2006, Diabetes & metabolism.

Metabolic roles of PGC-1α and its implications for type 2 diabetes.

J. Gautier, J. Riveline, A. Besseiche, 2015, Diabetes & metabolism.